PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Thursday reported a loss of $17.9 million in its second quarter.

The Pleasanton, California-based company said it had a loss of 14 cents per share.

The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 23 cents per share.

The life science technology company posted revenue of $151 million in the period, also beating Street forecasts. Seven analysts surveyed by Zacks expected $147 million.

10x Genomics expects full-year revenue in the range of $610 million to $630 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TXG at https://www.zacks.com/ap/TXG